@article{Buttel2010,
  added-at = {2011-03-21T12:21:35.000+0100},
  author = {Buttel, I C and Voller, K and Schneider, C K},
  biburl = {https://www.bibsonomy.org/bibtex/2b4d7476e4a7862917bc09e40f880e6c8/kalinke},
  editor = {Saf, Curr Drug},
  groups = {public},
  interhash = {53505cca09e0bf7bc4df178e98344d31},
  intrahash = {b4d7476e4a7862917bc09e40f880e6c8},
  journal = {Curr Drug Saf},
  keywords = {kalinke},
  number = 4,
  pages = {287-292},
  pubmedurl = {http://www.ncbi.nlm.nih.gov/pubmed/20615175},
  timestamp = {2012-05-30T13:08:07.000+0200},
  title = {Immunogenicity and its Impact on Benefit/Risk Considerations in the Authorisation of Biopharmaceuticals.},
  url = {http://www.ncbi.nlm.nih.gov/pubmed/20615175},
  username = {kalinke},
  volume = 5,
  year = 2010
}